date:Sep 20, 2012
first letter to really implement the provision of a 2009 draft guidance document that the FDA released regarding liquid supplements and beverages. In the letter, the FDA took issue with Revolts Slowtivate relaxation product. The FDA asserted that the product, labeled as a dietary supplement, did not meet the definition of a dietary supplement because the company, despite the labeling, represented the product as a beverage. As grounds for its assertions, the FDA referenced aspects such as the lab